PHASEBIO PHARMACEUTICALS INC - COM (PHASQ)

CUSIP: 717224109

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
18,531,408
Share change
-261,186
Total reported value
$77,265,227
Price per share
$4.17
Number of holders
56
Value change
-$12,431,516
Number of buys
32
Number of sells
17

Quarterly Holders Quick Answers

What is CUSIP 717224109?
CUSIP 717224109 identifies PHASQ - PHASEBIO PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) as of Q3 2019

As of 30 Sep 2019, PHASEBIO PHARMACEUTICALS INC - COM (PHASQ) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,531,408 shares. The largest 10 holders included NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Rock Springs Capital Management LP, BlackRock Inc., Cormorant Asset Management, LP, FARALLON CAPITAL MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, DAFNA Capital Management LLC, and STATE STREET CORP. This page lists 56 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.